Latest Earnings Results: Q3 '26
Estimated EPS
$0.52
Reported EPS
$0.58
Surprise
+11.92%
Estimated Rev
$2.91B
Reported Rev
$2.98B
Surprise
+2.34%
• Reported GAAP EPS of $0.58 down -15.94% YoY • Reported revenue of $2.98B up 4.97% YoY • Baxter raised FY 2026 reported sales growth guidance to 4% to 5%, organic sales growth to 3% to 4%, and adjusted diluted EPS to $2.05 to $2.15.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $0.60 | -- | -- | N/A |
Q3 '26 | $0.52 | $0.58 | 11.92% | BEAT |
Q2 '26 | $0.37 | $0.56 | 52.78% | BEAT |
Q1 '26 | $0.31 | $0.37 | 18.98% | BEAT |
Q4 '25 | $0.54 | $0.36 | -33.35% | MISSED |